These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 14574938

  • 1. [Therapeutic approach for colorectal cancer with topoisomerase as a molecular target].
    Tsunoda T.
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():472-5. PubMed ID: 14574938
    [No Abstract] [Full Text] [Related]

  • 2. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S, Aguado M, Fallik D, Praz F.
    Cancer Res; 2001 Sep 01; 61(17):6555-62. PubMed ID: 11522654
    [Abstract] [Full Text] [Related]

  • 3. Topoisomerase I-DNA covalent complexes in human colorectal cancer xenografts with different p53 and microsatellite instability status: relation with their sensitivity to CTP-11.
    Lansiaux A, Bras-Goncalves RA, Rosty C, Laurent-Puig P, Poupon MF, Bailly C.
    Anticancer Res; 2001 Sep 01; 21(1A):471-6. PubMed ID: 11299781
    [Abstract] [Full Text] [Related]

  • 4. An overview of topoisomerase I-targeting agents.
    Arbuck SG, Takimoto CH.
    Semin Hematol; 1998 Jul 01; 35(3 Suppl 4):3-12. PubMed ID: 9779876
    [Abstract] [Full Text] [Related]

  • 5. Clinical trials using irinotecan.
    Houghton PJ, Santana VM.
    J Pediatr Hematol Oncol; 2002 Feb 01; 24(2):84-5. PubMed ID: 11990709
    [No Abstract] [Full Text] [Related]

  • 6. [Irinotecan in colorectal cancer].
    Pozzo C, Cassano A, Barone C.
    Tumori; 2001 Feb 01; 87(1 Suppl 1):S49-50. PubMed ID: 11300023
    [No Abstract] [Full Text] [Related]

  • 7. FDA approves irinotecan as first-line therapy for colorectal cancer.
    Oncology (Williston Park); 2000 May 01; 14(5):652, 654. PubMed ID: 10853457
    [No Abstract] [Full Text] [Related]

  • 8. CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activity.
    Bleiberg H.
    Tumori; 1997 May 01; 83(1 Suppl):S85-6. PubMed ID: 9154078
    [No Abstract] [Full Text] [Related]

  • 9. [DNA topoisomerases targeting anticancer agents and mechanism for acquirement of drug resistance].
    Furukawa M, Harada T, Tanaka T, Kuwano M.
    Nihon Rinsho; 1997 May 01; 55(5):1096-102. PubMed ID: 9155159
    [Abstract] [Full Text] [Related]

  • 10. Camptothecins: new enthusiasm for an old drug.
    Rowe PM.
    Lancet; 1996 Mar 30; 347(9005):892. PubMed ID: 8622402
    [No Abstract] [Full Text] [Related]

  • 11. DNA topoisomerase I poisons.
    Takimoto CH, Kieffer LV, Kieffer ME, Arbuck SG, Wright J.
    Cancer Chemother Biol Response Modif; 1999 Mar 30; 18():81-124. PubMed ID: 10800479
    [No Abstract] [Full Text] [Related]

  • 12. Irinotecan hydrochloride.
    Wilkinson K.
    Clin J Oncol Nurs; 2001 Mar 30; 5(4):179-80, 184. PubMed ID: 12690622
    [No Abstract] [Full Text] [Related]

  • 13. Colorectal cancer chemotherapy: irinotecan.
    Rougier P, Mitry E.
    Semin Oncol; 2000 Oct 30; 27(5 Suppl 10):138-43. PubMed ID: 11049046
    [No Abstract] [Full Text] [Related]

  • 14. Topoisomerases in human leukemia.
    Peereboom D, Charron M, Kaufmann SH.
    Adv Pharmacol; 1994 Oct 30; 29B():33-50. PubMed ID: 8996600
    [No Abstract] [Full Text] [Related]

  • 15. Recent advances in topoisomerase I-targeting agents, camptothecin analogues.
    Kim DK, Lee N.
    Mini Rev Med Chem; 2002 Dec 30; 2(6):611-9. PubMed ID: 12370044
    [Abstract] [Full Text] [Related]

  • 16. Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere.
    Sato T, Hatate K, Ikeda A, Yamanashi T, Ozawa H, Onosato W, Nakamura T, Ihara A, Watanabe M.
    Expert Opin Pharmacother; 2008 May 30; 9(7):1223-8. PubMed ID: 18422478
    [Abstract] [Full Text] [Related]

  • 17. DNA topoisomerase I inhibitors.
    Takimoto CH, Kieffer LV, Arbuck SG.
    Cancer Chemother Biol Response Modif; 1997 May 30; 17():80-113. PubMed ID: 9551210
    [No Abstract] [Full Text] [Related]

  • 18. DNA topoisomerase inhibitors.
    Capranico G, Giaccone G, Zunino F, Garattini S, D'Incalci M.
    Cancer Chemother Biol Response Modif; 1994 May 30; 15():67-86. PubMed ID: 7779607
    [No Abstract] [Full Text] [Related]

  • 19. Irinotecan for colorectal cancer: a small step forward.
    O'Connell MJ.
    Lancet; 1998 Oct 31; 352(9138):1402. PubMed ID: 9807982
    [No Abstract] [Full Text] [Related]

  • 20. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
    Jung LL, Zamboni WC.
    Drug Resist Updat; 2001 Aug 31; 4(4):273-88. PubMed ID: 11998845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.